AngioDynamics (Albany, New York) said it has received clearance for its BioFlo Port with Endexo technology, a device designed to reduce the accumulation of cather-related thrombus on, and in, the port catheter. The company said the clearance of the BioFlo Port with Endexo technology marks the second U.S. clearance of a product line developed with BioFlo's technology.

Sometimes little nuggets of information don’t mean much, but sometimes they mean a lot. It’s not always clear, though, is it? Following are a couple such nuggets, but I’ll let the reader decide what they’re worth. In a recent congressional hearing, Sen. Patty Murray, said something that surely gave providers a nasty case of the hives. Murray, who chairs the Senate Budget Committee, said at a July 30 hearing that bundled payments “could help incentivize coordination and efficiency” by “creating fixed payments for...